News Formal

Eli Lilly appoints insider Lucas Montarce as new finance chief

  • 📰 CNBC
  • ⏱ Reading Time:
  • 46 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 46%
  • Publisher: 72%

Health Care Industry أخبار

Biotech And Pharmaceuticals,United States,Alphabet Inc

U.S. drugmaker Eli Lilly on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately.

on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi stepped down to join Google parent

The executive appointment comes at a crucial time for Eli Lilly as it invests billions to increase manufacturing capacity and meet unprecedented demand for its diabetes and weight loss drugs - Mounjaro and Zepbound.are leaders in the burgeoning market for new weight loss drugs, which some analysts project could exceed $150 billion by the early 2030s.

Montarce, who joined Lilly in 2001, has held various finance leadership roles, including the company's head of finance for Lilly Research Laboratories and Lilly International. Most recently, he served as the president and general manager for Lilly's Spain, Portugal, and Greece hub, a position he assumed earlier this year.

In addition to his CFO role, Montarce will serve as the drugmaker's executive vice president and, receive a base salary of $1 million, and be eligible for an annual target bonus of $1 million.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 12. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Stocks making the biggest premarket moves: KeyCorp, Starbucks, JetBlue, Eli Lilly and moreThese are the stocks posting the largest moves in the premarket.
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug marketEli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market. Meanwhile, Stryker will acquire artificial intelligence startup Care.ai.
مصدر: nbcchicago - 🏆 545. / 51 اقرأ أكثر »

Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug marketEli Lilly may be starting to gain an edge over Novo Nordisk in the GLP-1 market. Meanwhile, Stryker will acquire artificial intelligence startup Care.ai.
مصدر: NBCDFW - 🏆 288. / 63 اقرأ أكثر »

10 things to watch in the stock market Friday including more bullishness on Eli LillyWall Street is lower Friday morning after a strong session Thursday extended the market comeback.
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »